» Articles » PMID: 24655059

Systematic Screening of Compressed ODT Excipients: Cellulosic Versus Non-cellulosic

Overview
Journal Curr Drug Deliv
Specialty Pharmacology
Date 2014 Mar 25
PMID 24655059
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The successful development of compressed ODTs utilises low compression forces to create a porous structure whereby excipients are added to enhance wicking/swelling action or provide strength to the fragile tablet framework. In this work, a systematic investigation comparing materials from two different categories was employed to understand their functionality in binary mixture tablets of the most commonly used diluent mannitol. Cellulose based excipients such as HPC (SSL-SFP), L-HPC (NBD-022) and MCC (Avicel PH-102) were compared with non-cellulosic materials such as PEO (POLYOX WSR N-10) and Crospovidone (XL-10). Pure excipient properties were studied using Heckel Plot, compressibility profile, SEM and XRPD, whereas the prepared binary mixture compacts were studied for hardness, disintegration time and friability. Results from our investigation provide insight into differences encountered in product performance of ODT upon inclusion of additional materials. For example, non-cellulosic excipients Polyox and Crospovidone showed higher plasticity (Py values 588 and 450MPa) in pure form but not in binary mixtures of mannitol. Cellulosic excipients, nonetheless, offer faster disintegration (<30 sec) specifically L-HPC and MCC tablets. Disintegration time for tablets with fully substituted-HPC was prolonged (200-500 sec) upon increasing concentration between 1-10% due to gelation/ matrix formation. It can be concluded that despite the reasonably good plasticity of both cellulosic and noncellulosic excipients in pure form, the mechanical strength in binary mixtures is negatively impacted by the fragmentation/ fracture effect of mannitol.

Citing Articles

Novel ultra-stretchable and self-healing crosslinked poly (ethylene oxide)-cationic guar gum hydrogel.

Bernal-Chavez S, Alcala-Alcala S, Almarhoon Z, Turgumbayeva A, Sonmez Gurer E, De Los Dolores Campos-Echeverria M J Biol Eng. 2023; 17(1):64.

PMID: 37845737 PMC: 10577977. DOI: 10.1186/s13036-023-00376-2.


Quality by Design (QbD) based process optimisation to develop functionalised particles with modified release properties using novel dry particle coating technique.

Dahmash E, Al-Khattawi A, Iyire A, Al-Yami H, Dennison T, Mohammed A PLoS One. 2018; 13(11):e0206651.

PMID: 30383810 PMC: 6211725. DOI: 10.1371/journal.pone.0206651.


An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.

Alyami H, Dahmash E, Bowen J, Mohammed A PLoS One. 2017; 12(6):e0178772.

PMID: 28609454 PMC: 5469472. DOI: 10.1371/journal.pone.0178772.


An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.

Shojaee S, Emami P, Mahmood A, Rowaiye Y, Dukulay A, Kaialy W AAPS PharmSciTech. 2015; 16(6):1281-9.

PMID: 25771738 PMC: 4666262. DOI: 10.1208/s12249-015-0295-z.


Evidence-based nanoscopic and molecular framework for excipient functionality in compressed orally disintegrating tablets.

Al-Khattawi A, Alyami H, Townsend B, Ma X, Mohammed A PLoS One. 2014; 9(7):e101369.

PMID: 25025427 PMC: 4098910. DOI: 10.1371/journal.pone.0101369.